TY - JOUR
T1 - Assessment of spatio-temporal gait parameters using inertial measurement units in neurological populations
AU - Esser, P
AU - Dawes, H
AU - Collett, J
AU - Feltham, Maxwell
AU - Howells, K
PY - 2011/10/1
Y1 - 2011/10/1
N2 - Laboratory based gait analysis techniques are expensive, time consuming and require technical expertise. Inertial measurement units can directly measure temporal parameters and in combination with gait models may provide a solution to obtain spatial gait measurements within daily clinical assessments. However it is not known if a model and standard correction factor determined by Zijlstra and Hof [8] to estimate step and stride length parameters in typically developed adults (TDA) can be accurately used in neurologically impaired gaits. This research estimated the stride length over two 10 m walks at self selected walking speed in people with neurological conditions, using a previously established model and correction factor for TDA. The relation of the correction factor to walking speed was explored. We recruited TDA (n=10) and participants with Parkinson's disease (PD; n=24), muscular dystrophy (MD; n=13), motor neuron disease (MND; n=7) and stroke survivors (n=18) for the study who twice walked 10 m at a self-selected pace. Stride length correction factors, for TDA (1.25±0.01), PD (1.25±0.03), and MD (1.21±0.08) (p=0.833 and p=0.242) were the same as previously reported in TDA (Zijlstra and Hof [8]). Correction factors for stroke (1.17±0.42) and MND (1.10±0.08) were different (p
AB - Laboratory based gait analysis techniques are expensive, time consuming and require technical expertise. Inertial measurement units can directly measure temporal parameters and in combination with gait models may provide a solution to obtain spatial gait measurements within daily clinical assessments. However it is not known if a model and standard correction factor determined by Zijlstra and Hof [8] to estimate step and stride length parameters in typically developed adults (TDA) can be accurately used in neurologically impaired gaits. This research estimated the stride length over two 10 m walks at self selected walking speed in people with neurological conditions, using a previously established model and correction factor for TDA. The relation of the correction factor to walking speed was explored. We recruited TDA (n=10) and participants with Parkinson's disease (PD; n=24), muscular dystrophy (MD; n=13), motor neuron disease (MND; n=7) and stroke survivors (n=18) for the study who twice walked 10 m at a self-selected pace. Stride length correction factors, for TDA (1.25±0.01), PD (1.25±0.03), and MD (1.21±0.08) (p=0.833 and p=0.242) were the same as previously reported in TDA (Zijlstra and Hof [8]). Correction factors for stroke (1.17±0.42) and MND (1.10±0.08) were different (p
U2 - 10.1016/j.gaitpost.2011.06.018
DO - 10.1016/j.gaitpost.2011.06.018
M3 - Article
C2 - 21764583
SN - 1879-2219
VL - 34
SP - 558
EP - 560
JO - Gait and Posture
JF - Gait and Posture
IS - 4
ER -